Medable Adds New Oncology Offering


Medable announced a new oncology offering. It is an end-to-end suite that includes DCT applications such as Total Consent and Televisit, an eCOA oncology library, and protocol design consulting—with a single point of entry for patients, sites, and sponsors.

Read more about the new offering here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.